ERBB2 and breast cancer: The MRI-based radiomic approach developed in this work, built on a comprehensive BC dataset including MRI sequences and molecular outcomes, can efficiently characterize BC heterogeneity according to the most examined biomarkers (ER, PR, HER2, and Ki67).